A citation-based method for searching scientific literature

D Malkin, F P Li, L C Strong, J F Fraumeni, C E Nelson, D H Kim, J Kassel, M A Gryka, F Z Bischoff, M A Tainsky. Science 1990
Times Cited: 2971







List of co-cited articles
724 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers.
Gaëlle Bougeard, Mariette Renaux-Petel, Jean-Michel Flaman, Camille Charbonnier, Pierre Fermey, Muriel Belotti, Marion Gauthier-Villars, Dominique Stoppa-Lyonnet, Emilie Consolino, Laurence Brugières,[...]. J Clin Oncol 2015
255
25

Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
Phuong L Mai, Ana F Best, June A Peters, Rosamma M DeCastro, Payal P Khincha, Jennifer T Loud, Renée C Bremer, Philip S Rosenberg, Sharon A Savage. Cancer 2016
167
19

Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
Kelly D Gonzalez, Katie A Noltner, Carolyn H Buzin, Dongqing Gu, Cindy Y Wen-Fong, Vu Q Nguyen, Jennifer H Han, Katrina Lowstuter, Jeffrey Longmate, Steve S Sommer,[...]. J Clin Oncol 2009
330
17

Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.
S Srivastava, Z Q Zou, K Pirollo, W Blattner, E H Chang. Nature 1990
16

Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome.
Christian P Kratz, Maria Isabel Achatz, Laurence Brugières, Thierry Frebourg, Judy E Garber, Mary-Louise C Greer, Jordan R Hansford, Katherine A Janeway, Wendy K Kohlmann, Rose McGee,[...]. Clin Cancer Res 2017
163
15

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.
Anita Villani, Ari Shore, Jonathan D Wasserman, Derek Stephens, Raymond H Kim, Harriet Druker, Bailey Gallinger, Anne Naumer, Wendy Kohlmann, Ana Novokmet,[...]. Lancet Oncol 2016
214
15

A cancer family syndrome in twenty-four kindreds.
F P Li, J F Fraumeni, J J Mulvihill, W A Blattner, M G Dreyfus, M A Tucker, R W Miller. Cancer Res 1988
950
15

TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data.
Liacine Bouaoun, Dmitriy Sonkin, Maude Ardin, Monica Hollstein, Graham Byrnes, Jiri Zavadil, Magali Olivier. Hum Mutat 2016
312
13

TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
Marielle W G Ruijs, Senno Verhoef, Matti A Rookus, Roelof Pruntel, Annemarie H van der Hout, Frans B L Hogervorst, I Kluijt, Rolf H Sijmons, Cora M Aalfs, Anja Wagner,[...]. J Med Genet 2010
164
12

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
11

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.
L A Donehower, M Harvey, B L Slagle, M J McArthur, C A Montgomery, J S Butel, A Bradley. Nature 1992
11

Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
Magali Olivier, David E Goldgar, Nayanta Sodha, Hiroko Ohgaki, Paul Kleihues, Pierre Hainaut, Rosalind A Eeles. Cancer Res 2003
289
10

Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis.
Shunsuke Kato, Shuang-Yin Han, Wen Liu, Kazunori Otsuka, Hiroyuki Shibata, Ryunosuke Kanamaru, Chikashi Ishioka. Proc Natl Acad Sci U S A 2003
496
10

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study.
Anita Villani, Uri Tabori, Joshua Schiffman, Adam Shlien, Joseph Beyene, Harriet Druker, Ana Novokmet, Jonathan Finlay, David Malkin. Lancet Oncol 2011
242
9

Sensitivity and predictive value of criteria for p53 germline mutation screening.
A Chompret, A Abel, D Stoppa-Lyonnet, L Brugiéres, S Pagés, J Feunteun, C Bonaïti-Pellié. J Med Genet 2001
178
9

Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.
K E Nichols, D Malkin, J E Garber, J F Fraumeni, F P Li. Cancer Epidemiol Biomarkers Prev 2001
233
9

Mutational landscape and significance across 12 major cancer types.
Cyriac Kandoth, Michael D McLellan, Fabio Vandin, Kai Ye, Beifang Niu, Charles Lu, Mingchao Xie, Qunyuan Zhang, Joshua F McMichael, Matthew A Wyczalkowski,[...]. Nature 2013
9

Multiple primary cancers in families with Li-Fraumeni syndrome.
M Hisada, J E Garber, C Y Fung, J F Fraumeni, F P Li. J Natl Cancer Inst 1998
348
9

Prediction of pathogenic mutations in patients with early-onset breast cancer by family history.
Fiona Lalloo, Jennifer Varley, David Ellis, Anthony Moran, Lindsay O'Dair, Paul Pharoah, D Gareth R Evans. Lancet 2003
118
8

Somatic TP53 variants frequently confound germ-line testing results.
Jeffrey N Weitzel, Elizabeth C Chao, Bita Nehoray, Lily R Van Tongeren, Holly LaDuca, Kathleen R Blazer, Thomas Slavin, D A B M D Facmg, Tina Pesaran, Christina Rybak,[...]. Genet Med 2018
54
14

Li-fraumeni syndrome.
David Malkin. Genes Cancer 2011
209
8

p53 mutations in human cancers.
M Hollstein, D Sidransky, B Vogelstein, C C Harris. Science 1991
8

Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis.
Mandy L Ballinger, Ana Best, Phuong L Mai, Payal P Khincha, Jennifer T Loud, June A Peters, Maria Isabel Achatz, Rubens Chojniak, Alexandre Balieiro da Costa, Karina Miranda Santiago,[...]. JAMA Oncol 2017
86
9

Mutational processes shape the landscape of TP53 mutations in human cancer.
Andrew O Giacomelli, Xiaoping Yang, Robert E Lintner, James M McFarland, Marc Duby, Jaegil Kim, Thomas P Howard, David Y Takeda, Seav Huong Ly, Eejung Kim,[...]. Nat Genet 2018
94
8

Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.
Jonathan D Wasserman, Ana Novokmet, Claudia Eichler-Jonsson, Raul C Ribeiro, Carlos Rodriguez-Galindo, Gerard P Zambetti, David Malkin. J Clin Oncol 2015
87
9

Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil.
Edenir Inêz Palmero, Lavínia Schüler-Faccini, Maira Caleffi, Maria Isabel Waddington Achatz, Magali Olivier, Ghyslaine Martel-Planche, Virginie Marcel, Ernestina Aguiar, Juliana Giacomazzi, Ingrid Petroni Ewald,[...]. Cancer Lett 2008
69
11


Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.
J M Birch, A L Hartley, K J Tricker, J Prosser, A Condie, A M Kelsey, M Harris, P H Jones, A Binchy, D Crowther. Cancer Res 1994
401
7

Putting p53 in Context.
Edward R Kastenhuber, Scott W Lowe. Cell 2017
565
7

Germline Mutations in Predisposition Genes in Pediatric Cancer.
Jinghui Zhang, Michael F Walsh, Gang Wu, Michael N Edmonson, Tanja A Gruber, John Easton, Dale Hedges, Xiaotu Ma, Xin Zhou, Donald A Yergeau,[...]. N Engl J Med 2015
473
7

The genomic landscape of hypodiploid acute lymphoblastic leukemia.
Linda Holmfeldt, Lei Wei, Ernesto Diaz-Flores, Michael Walsh, Jinghui Zhang, Li Ding, Debbie Payne-Turner, Michelle Churchman, Anna Andersson, Shann-Ching Chen,[...]. Nat Genet 2013
359
7

The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
Maria Isabel Waddington Achatz, Magali Olivier, Florence Le Calvez, Ghyslaine Martel-Planche, Ademar Lopes, Benedito Mauro Rossi, Patricia Ashton-Prolla, Roberto Giugliani, Edenir Inez Palmero, Fernando Regla Vargas,[...]. Cancer Lett 2007
125
7

Contribution of de novo and mosaic TP53 mutations to Li-Fraumeni syndrome.
Mariette Renaux-Petel, Françoise Charbonnier, Jean-Christophe Théry, Pierre Fermey, Gwendoline Lienard, Jacqueline Bou, Sophie Coutant, Myriam Vezain, Edwige Kasper, Steeve Fourneaux,[...]. J Med Genet 2018
34
20

2009 version of the Chompret criteria for Li Fraumeni syndrome.
Julie Tinat, Gaelle Bougeard, Stéphanie Baert-Desurmont, Stéphanie Vasseur, Cosette Martin, Emilie Bouvignies, Olivier Caron, Brigitte Bressac-de Paillerets, Pascaline Berthet, Catherine Dugast,[...]. J Clin Oncol 2009
192
7

Mdm2 promotes the rapid degradation of p53.
Y Haupt, R Maya, A Kazaz, M Oren. Nature 1997
7


Inherited TP53 Mutations and the Li-Fraumeni Syndrome.
Tanya Guha, David Malkin. Cold Spring Harb Perspect Med 2017
58
12


Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database.
Simona Ognjanovic, Magali Olivier, Tracy L Bergemann, Pierre Hainaut. Cancer 2012
132
7

Variable population prevalence estimates of germline TP53 variants: A gnomAD-based analysis.
Kelvin C de Andrade, Megan N Frone, Talia Wegman-Ostrosky, Payal P Khincha, Jung Kim, Amina Amadou, Karina M Santiago, Fernanda P Fortes, Nathanaël Lemonnier, Lisa Mirabello,[...]. Hum Mutat 2019
27
25

Germline mutations in the TP53 gene.
R A Eeles. Cancer Surv 1995
144
6

TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors.
Uri Tabori, Adam Shlien, Berivan Baskin, Sarah Levitt, Peter Ray, Noa Alon, Cynthia Hawkins, Eric Bouffet, Malgorzata Pienkowska, Lucie Lafay-Cousin,[...]. J Clin Oncol 2010
94
6

Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.
S J Baker, E R Fearon, J M Nigro, S R Hamilton, A C Preisinger, J M Jessup, P vanTuinen, D H Ledbetter, D F Barker, Y Nakamura,[...]. Science 1989
6

A global reference for human genetic variation.
Adam Auton, Lisa D Brooks, Richard M Durbin, Erik P Garrison, Hyun Min Kang, Jan O Korbel, Jonathan L Marchini, Shane McCarthy, Gil A McVean, Gonçalo R Abecasis. Nature 2015
6

Analysis of protein-coding genetic variation in 60,706 humans.
Monkol Lek, Konrad J Karczewski, Eric V Minikel, Kaitlin E Samocha, Eric Banks, Timothy Fennell, Anne H O'Donnell-Luria, James S Ware, Andrew J Hill, Beryl B Cummings,[...]. Nature 2016
6

An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma.
R C Ribeiro, F Sandrini, B Figueiredo, G P Zambetti, E Michalkiewicz, A R Lafferty, L DeLacerda, M Rabin, C Cadwell, G Sampaio,[...]. Proc Natl Acad Sci U S A 2001
335
6

Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort.
Serena Masciari, Deborah A Dillon, Michelle Rath, Mark Robson, Jeffrey N Weitzel, Judith Balmana, Stephen B Gruber, James M Ford, David Euhus, Alexandra Lebensohn,[...]. Breast Cancer Res Treat 2012
88
6

Diagnosis of Li-Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis: Results of the observational AGO-TR1 trial.
Konstantin Weber-Lassalle, Philipp Harter, Jan Hauke, Corinna Ernst, Stefan Kommoss, Frederik Marmé, Nana Weber-Lassalle, Katharina Prieske, Dimo Dietrich, Julika Borde,[...]. Hum Mutat 2018
12
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.